CPBTD
PFE icon

Central Pacific Bank - Trust Division’s Pfizer PFE Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$664K Sell
23,291
-10
-0% -$266 0.07% 250
2026
Q2 		$561K Buy
23,301
+756
+3% +$19.8K 0.06% 301
2026
Q1 		$633K Buy
22,545
+387
+2% +$10.3K 0.08% 248
2025
Q4 		$552K Sell
22,158
-1,335
-6% -$33.7K 0.07% 274
2025
Q3 		$599K Sell
23,493
-280
-1% -$6.91K 0.07% 257
2025
Q2 		$576K Buy
23,773
+2,139
+10% +$49.9K 0.07% 260
2025
Q1 		$548K Buy
21,634
+3,516
+19% +$92K 0.08% 239
2024
Q4 		$481K Buy
18,118
+8,832
+95% +$240K 0.06% 273
2024
Q3 		$269K Buy
9,286
+3,880
+72% +$113K 0.03% 404
2024
Q2 		$151K Buy
5,406
+500
+10% +$13.8K 0.02% 595
2024
Q1 		$136K Buy
+4,906
New +$136K 0.02% 617

Other funds holding PFE

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

Central Pacific Bank - Trust Division's PFE Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its Pfizer (PFE) stake by 0.04% in Q3 2026, selling an estimated $266 and leaving 23,291 shares worth $664K. The position accounts for 0.07% of the portfolio, ranked #250.

Central Pacific Bank - Trust Division first reported a position in PFE in Q1 2024 and has held it in 11 quarters since. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Central Pacific Bank - Trust Division held 23,291 shares of Pfizer worth $664K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 10 Pfizer shares in Q3 2026, an estimated $266.
  • Pfizer made up 0.07% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #250 holding.
  • Central Pacific Bank - Trust Division first reported a position in Pfizer in Q1 2024 and has held it in 11 quarters since.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.